CEO Christian Henry highlighted Q4 2024 revenue of $39.2 million, driven by the shipment of 23 Revio systems and the early shipment of seven Vega benchtop platforms, which exceeded schedule. Full-year ...

By exactly how much, the biotech is not sharing, saying simply that it is “reducing its workforce,” but “intends to retain all employees essential for supporting value-realization as part of ...